Zortix matched this thesis to Biotech ETFs as one way for retail investors to get exposure. Not a recommendation.
Redefining value for biotech: market cap to spend
The thesis presented was that traditional value factors fail in biotech, and the effective metric is market cap relative to research & development spend.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.